The Global Granulomatous Lobular Mastitis Treatment Market is expected to witness significant growth during the forecast period. G.M. is a rare differential diagnosis with an estimated prevalence of 2.4 per 100,000 women and 0.37 percent in the U.S. Both the practitioner and the patient who frequently has to endure a protracted disease course with a major impact on quality of life still find it difficult to diagnose and treat a patient with G.M. Before the diagnosis of G.M. can be considered, many causes of mastitis, and most especially cancer, typically need to be ruled out.
Like
Comment
Share
